Peter Shaw
11Patents
5h-index
27Co-inventors
66Inventor score
Filing activity: May 5, 1980 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4468811A | Tamper-evident closure for bag | Emerging Cross-Sectional Technologies | 53 | Expired |
| US7932031B2 | Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1 | Physics | 11 | Active |
| US4331491A | Method of making packaging using a tinted adhesive laminate | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5891696A | Compositions for cytochrome P450 biotransformation reactions | Chemistry; Metallurgy | 7 | Expired |
| US7537891B2 | Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells | Chemistry; Metallurgy | 5 | Expired |
| US9932637B2 | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof | Physics | 2 | Active |
| US7504211B2 | Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells | Chemistry; Metallurgy | 2 | Expired |
| US6319678A | Process for glucuronidation screening | Physics | 2 | Expired |
| US11708610B2 | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof | Physics | 0 | Active |
| US10982281B2 | Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof | Physics | 0 | Active |
| US12071666B2 | Human genetic markers associated with response to treatments that target clostridium difficile toxin B | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.